Close X
 
 

An interesting journey


[email protected]

 
 
 
 

Insulin’s place in the treatment of people with type 2 diabetes has been transformed by the advent of new drugs, says Professor Tina Vilsbøll (Steno Diabetes Centre, Denmark). But with fixed-ratio combinations and once-weekly insulin injections in the pipeline, the journey isn’t over yet.

 
 

Further learning

For more on the issues raised in this presentation, see our course on GLP-1 receptor agonists.

 
WP_Post Object ( [ID] => 38137 [post_author] => 2 [post_date] => 2022-07-05 10:02:41 [post_date_gmt] => 2022-07-05 09:02:41 [post_content] => [post_title] => Multimorbidity and diabetes [post_excerpt] => [post_status] => private [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => multimorbidity-and-diabetes [to_ping] => [pinged] => [post_modified] => 2022-07-30 13:39:53 [post_modified_gmt] => 2022-07-30 12:39:53 [post_content_filtered] => [post_parent] => 0 [guid] => https://easd-elearning.org/?post_type=sfwd-courses&p=38137 [menu_order] => 0 [post_type] => sfwd-courses [post_mime_type] => [comment_count] => 0 [filter] => raw )
Launching soon
Multimorbidity and diabetes
See all our upcoming courses
More like this
© EASD 2022